Evidence map›Paper›PMID 19432455›Full record

ReviewMolecular pharmaceutics

Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.

Chiranjeevi Peetla, Andrew Stine, Vinod Labhasetwar

Abstract readReview
In one paragraph

Review in Molecular pharmaceutics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 538 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. DNA-Lipid Nanodiscs with a Polyethylene Glycol Interface.Journal of the American Chemical Society · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Molecular Interactions of Fluoroquinolone Antibiotics with Lipid Membranes.Langmuir : the ACS journal of surfaces and colloids · 2026
    Article
  13. Article
  14. Review
  15. Inhalable nanoparticle-based drug delivery system for non-small cell lung cancer therapy: promises and challenges.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Review
  16. Review
  17. Article
  18. Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  19. Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chiranjeevi PeetlaDepartment of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Andrew Stine
Vinod Labhasetwar
Cleveland Clinic Lerner College of Medicine · US

Funding

Nuclear-targeted nanoparticles for gene deliveryR01EB003975 · NIBIB · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LABHASETWAR, VINOD D · 2005 to 2008
$1.1M
TAT-Peptide conjugated nanoparticles for CNS DeliveryR21MH067525 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LABHASETWAR, VINOD D · 2004 to 2005
$458k
NIBIB NIH HHS 1R01 EB 003975NIBIB NIH HHS R01 EB003975NIMH NIH HHS R21 MH06 7525NIMH NIH HHS R21 MH067525
6 · The paper itself

Abstract

The transport of drugs or drug delivery systems across the cell membrane is a complex biological process, often difficult to understand because of its dynamic nature. In this regard, model lipid membranes, which mimic many aspects of cell-membrane lipids, have been very useful in helping investigators to discern the roles of lipids in cellular interactions. One can use drug-lipid interactions to predict pharmacokinetic properties of drugs, such as their transport, biodistribution, accumulation, and hence efficacy. These interactions can also be used to study the mechanisms of transport, based on the structure and hydrophilicity/hydrophobicity of drug molecules. In recent years, model lipid membranes have also been explored to understand their mechanisms of interactions with peptides, polymers, and nanocarriers. These interaction studies can be used to design and develop efficient drug delivery systems. Changes in the lipid composition of cells and tissue in certain disease conditions may alter biophysical interactions, which could be explored to develop target-specific drugs and drug delivery systems. In this review, we discuss different model membranes, drug-lipid interactions and their significance, studies of model membrane interactions with nanocarriers, and how biophysical interaction studies with lipid model membranes could play an important role in drug discovery and drug delivery.

Indexed as

Drug Delivery SystemsDrug DiscoveryBiophysical PhenomenaLipid BilayersLiposomesMembrane LipidsMembranes, ArtificialModels, MolecularNanostructuresNanotechnologyPolymersLipid BilayersLiposomesMembrane LipidsMembranes, ArtificialPolymers

Identifiers

PMID19432455
PMCPMC2757518
OpenAlexW2091402748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.